Palbociclib Combo Tops Chemo in High-Risk Breast Cancer ...Middle East

Medscape - News
The Phase III PADMA trial showed that palbociclib plus endocrine therapy doubled progression-free survival compared with chemotherapy in high-risk HR+/HER2− metastatic breast cancer. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Palbociclib Combo Tops Chemo in High-Risk Breast Cancer )

Also on site :